调节器
医学
肾素-血管紧张素系统
血管紧张素II
激素
内科学
内分泌学
受体
血压
内生
分流(医疗)
血管紧张素受体阻滞剂
血管活性
血管紧张素转换酶
药理学
高血压的病理生理学
慢性高血压
血管紧张素受体
基因
酶
遗传增强
医疗
生物信息学
生物标志物
基因表达
心脏病学
信号转导
癌症研究
作者
Gokberk Unal,Maysam Mansouri,Yuqing Xie,Christian Eugen Mueller,Ghislaine Charpin‐El Hamri,Martin Fussenegger
标识
DOI:10.1038/s41467-026-71796-z
摘要
Arterial hypertension is the leading preventable cause of various life-threatening medical conditions and comorbidities that affect over 1.3 billion adults, causing over 7.5 million annual deaths worldwide. Capitalizing on a synthetic biology-inspired engineering approach, we design a fully human, antihypertensive gene circuit called ARCH (autonomous regulator of chronic hypertension), which precisely monitors and efficiently controls angiotensin-dependent, renin-angiotensin system (RAS)-driven hypertension, in which angiotensin II (Ang-II) is persistently elevated, in a reversible, self-sufficient, and closed-loop manner. We utilize the ectopically expressed native type-1 angiotensin receptor (AT 1 R) to monitor the blood level of the hypertension biomarker Ang-II. We then rewire the AT 1 R activation during hypertension to a synthetic promoter to coordinate the expression of clinically licensed, secretion-engineered, soluble therapeutic angiotensin-converting enzyme 2 (stACE2), which degrades Ang-II and restores normotension. Implantation of microencapsulated ARCH-transgenic human cells into male hypertensive mice restores and maintains normal blood pressure.
科研通智能强力驱动
Strongly Powered by AbleSci AI